Form 4: Encompass Health Director Boosts Equity Stake Through Dividend Reinvestment

Encompass Health Corp. Director Nancy M. Schlichting acquired 34 additional restricted stock units on July 15, 2025, as part of a dividend reinvestment program, increasing her total beneficial ownership to 21,186 units.

Summary

• Nancy M. Schlichting, a Director of Encompass Health Corp. (EHC), acquired 34 restricted stock units (RSUs).
• The acquisition occurred on July 15, 2025.
• This transaction was an award of RSUs associated with a common stock dividend payment.
• Encompass Health paid a dividend of $0.17 per share on its common stock.
• The closing price of Encompass Health common stock on the dividend payment date was $107.28.
• The number of RSUs credited is calculated based on existing RSUs, the per share dividend, and the closing price.
• Following this transaction, Nancy M. Schlichting beneficially owns 21,186 units.

Sentiment

Score: 7

Explanation: The transaction is a routine, positive event where a director increases their equity stake through a standard compensation mechanism tied to dividends, aligning interests with shareholders. It's not a major market-moving event but reflects ongoing director engagement and a return of capital to shareholders.

Positives

• Director Nancy M. Schlichting increased her beneficial ownership in Encompass Health Corp. through the acquisition of 34 restricted stock units.
• The acquisition of RSUs is tied to a common stock dividend payment, indicating a return of capital to shareholders and aligning director interests with shareholder value.

Future Outlook

This Form 4 filing primarily reports a past transaction related to equity compensation and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Management Comments

• Additional restricted stock units are credited to non-employee directors' accounts in connection with common stock dividend payments, reflecting a standard equity compensation practice.

Industry Context

This transaction is a routine insider filing (Form 4) reporting a director's acquisition of equity through a dividend reinvestment mechanism, common in many publicly traded companies across various industries to align director interests with shareholders.

Comparison to Industry Standards

• The practice of granting restricted stock units (RSUs) as part of non-employee director compensation, often including dividend equivalent rights, is a standard corporate governance practice across industries, including healthcare.
• Companies like HCA Healthcare (HCA) and Universal Health Services (UHS) also utilize equity-based compensation to align director incentives with long-term shareholder value. The specific dividend yield and RSU conversion mechanism are company-specific but the underlying principle of equity-based compensation for directors is a widely accepted benchmark.

Stakeholder Impact

• Shareholders: The transaction reflects a director's increased alignment with shareholder interests through equity ownership and the company's ongoing dividend payments.

Next Steps

• No specific future actions or milestones are mentioned in this Form 4 filing beyond the reported transaction.

Key Dates

Keywords

Encompass Health Corp, EHC, Nancy M. Schlichting, Director, Restricted Stock Units, RSU, Dividend Reinvestment, Insider Ownership, SEC Form 4, Equity Compensation